New First-Line Option for Advanced ALK-Positive Lung Cancer

Published Date: 20 Dec 2024

In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

2.

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

3.

Many women undergo annual mammography, despite biennial screening recommendations

4.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

5.

After two years, a significant left nasal obstruction was finally diagnosed.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot